Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Radiation therapy for malignant lymphoma].

Y Ito1, S Ishikura, T Ogino

  • 1Division of Radiation Oncology, National Cancer Center Hospital East.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|March 31, 2000
PubMed
Summary

Radiation therapy (RT) plays a key role in treating malignant lymphoma (ML). RT alone is recommended for early-stage Hodgkin

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Purification and characterization of DNA topoisomerase IV in Escherichia coli.

The Journal of biological chemistry·1992
Same author

Prognostic factor of telecobalt therapy for early glottic carcinoma.

Cancer·1992
Same author

[Adult T-cell leukemia with various pulmonary complications].

Nihon Kyobu Shikkan Gakkai zasshi·1992
Same author

Sulfur amino acid levels and related enzyme activities in various brain regions (and other tissues) in normal mice and rolling mice Nagoya.

Acta medica Okayama·1992
Same author

[Adult T-cell leukemia/lymphoma, histologically presenting Ki-1 positive anaplastic large cell lymphoma].

[Rinsho ketsueki] The Japanese journal of clinical hematology·1992
Same author

Phase I/II study of high-dose rate interstitial radiotherapy for head and neck cancer.

Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]·1992

Area of Science:

  • Oncology
  • Radiation Oncology
  • Hematology

Context:

  • Malignant lymphoma (ML) treatment requires understanding clinical features.
  • Radiation therapy (RT) is being re-evaluated for ML treatment efficacy.
  • Combined modality treatment (CMT) shows effectiveness in early-stage aggressive non-Hodgkin's lymphoma (NHL).

Purpose:

  • To evaluate the role of radiation therapy (RT) in the treatment of malignant lymphoma (ML).
  • To analyze the effectiveness of combined modality treatment (CMT) versus RT alone for different lymphoma types.
  • To provide recommendations for RT use in early-stage Hodgkin's disease (HD) and mucosa-associated lymphoid tissue (MALT) lymphoma.

Summary:

  • Adjuvant RT to bulky sites in advanced-stage aggressive NHL may improve survival outcomes.
  • For early-stage Hodgkin's disease (HD), RT alone with adequate field is recommended over CMT or extended RT.
  • Low-grade mucosa-associated lymphoid tissue (MALT) lymphoma is highly responsive to RT and potentially curable.

Impact:

  • RT strategies can be optimized for different ML subtypes, improving patient outcomes.
  • Findings support the use of RT alone for early-stage HD, potentially reducing treatment toxicity.
  • RT offers a curative option for low-grade MALT lymphoma, highlighting its radiosensitivity.

Related Experiment Videos